Evidence map›Paper›PMID 26672616›Full record

ArticleAmerican journal of physiology. Renal physiology2016

Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney.

Chunling Li, Yu Lin, Renfei Luo, Shaoming Chen, Feifei Wang, Peili Zheng, Moshe Levi, Tianxin Yang, Weidong Wang

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Maternal High-Fat Diet and Offspring Hypertension.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chunling LiInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;
Yu LinInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;
Renfei LuoInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;
Shaoming ChenDepartment of Orthopedics, The 5th Affiliated Hospital, Sun Yat-sen University, Zhuhai, China;
Feifei WangInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; wangwd6@mail.sysu.edu.cn.
Peili ZhengInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;
Moshe LeviDepartment of Medicine, Division of Hypertension and Renal Diseases, University of Colorado Denver, Aurora, Colorado; and.
Tianxin YangInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; Department of Medicine, Division of Renal Diseases and Hypertension, University of Utah, Salt Lake City, Utah.
Weidong WangInstitute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China;
Sun Yat-sen University · CNUniversity of Colorado Denver · USUniversity of Utah · US

Funding

Treatment of Kidney Disease in Diabetes and ObesityR01DK098336 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LEVI, MOSHE · 2013 to 2016
$1.3M
NIDDK NIH HHS R01 DK098336
6 · The paper itself

Abstract

Obesity-related kidney disease is related to caloric excess promoting deleterious cellular responses. Accumulation of saturated free fatty acids in tubular cells produces lipotoxicity involving significant cellular dysfunction and injury. The objectives of this study were to elucidate the role of renin-angiotensin system (RAS) activation in saturated fatty acid-induced endoplasmic reticulum (ER) stress in cultured human proximal tubule epithelial cells (HK2) and in mice fed with a high-fat diet. Treatment with saturated fatty acid palmitic acid (PA; 0.8 mM) for 24 h induced ER stress in HK2, leading to an unfolded protein response as reflected by increased expressions of the ER chaperone binding immunoglobulin protein (BiP) and proapoptotic transcription factor C/EBP homologous protein (CHOP) protein as evaluated by immunoblotting. PA treatment also induced increased protein expression of inositol requiring protein 1α (IRE1α), phosphorylated eukaryotic initiation factor-α (eIF2α), and activating transcription factor 4 (ATF4) as well as activation of caspase-3. PA treatment was associated with increased angiotensin II levels in cultured medium. The angiotensin II type 1 receptor (AT1R) blocker valsartan or renin inhibitor aliskiren dramatically suppressed PA-induced upregulation of BiP, CHOP, IRE1α, p-eIF2α, and ATF4 in HK2 cells. In contrast, valsartan or aliskiren did not prevent ER stress induced by tunicamycin. C57BL/6 mice fed with a high-fat diet for 14 wk exhibited increased protein expressions of BiP and CHOP compared with control mice, which were significantly attenuated by the valsartan treatment. Increased angiotensin II levels in serum and urine were observed in mice fed with a high-fat diet when compared with controls. It is suggested that the intrarenal RAS activation may play an important role in diabetic kidney injury via mediating ER stress induced by saturated fatty acid.

Indexed as

Diet, High-FatAmidesAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsApoptosisBlood GlucoseCell LineCell SurvivalDisease Models, AnimalDose-Response Relationship, DrugEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressFumaratesGene Expression RegulationHeat-Shock ProteinsaliskirenAmidesAngiotensin IIAngiotensin II Type 1 Receptor BlockersBlood GlucoseDDIT3 protein, humanDdit3 protein, mouseEndoplasmic Reticulum Chaperone BiPFumaratesHeat-Shock ProteinsPalmitic AcidRNA, MessengerTranscription Factor CHOPTunicamycinValsartanangiotensin IIkidneysaturated fatty acidvalsartan

Identifiers

PMID26672616
PMCPMC4971807
OpenAlexW2239670076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.